Cysteinyl 1 Receptor Antagonist Montelukast, Does Not Prevent Peritoneal Membrane Damage in Experimental Chronic Peritoneal Dialysis Model in Rats
Background/Aims: Continuous ambulatory peritoneal dialysis (CAPD) induces structural changes in the peritoneal membrane such as fibrosis, vasculopathy and angioneogenesis with a reduction in ultrafiltration capacity. Leukotriene (LT) receptor antagonists have been found to be effective to prevent fi...
Saved in:
Main Authors: | Sibel Koçak Yucel (Author), Hakki Arikan (Author), Halil Tugtepe (Author), Fulya Cakalagaoglu (Author), Serhan Tuglular (Author), Emel Akoglu (Author), Cetin Ozener (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2014-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unusual causes of peritonitis in a peritoneal dialysis patient: Alcaligenes faecalis and Pantoea agglomerans
by: Arikan Hakki, et al.
Published: (2011) -
Chylous peritonitis in peritoneal dialysis
by: Hanen Abid, et al.
Published: (2021) -
Therapeutic advances of peritoneal dialysis-associated peritonitis
by: Qiu Deng, et al.
Published: (2024) -
Peritoneal-pleural leak improved by switching from continuous ambulatory peritoneal dialysis to automated peritoneal dialysis
by: Jong Hwan Jung
Published: (2018) -
Case Report: Recurring Peritonitis and Dialysis Failure in a Toddler on Peritoneal Dialysis
by: Enas H. Mohammed, et al.
Published: (2021)